{"created":"2023-06-23T12:13:42.356794+00:00","id":1850,"links":{},"metadata":{"_buckets":{"deposit":"86f0f7a8-4fd6-47d5-a130-33d2a5bdb6e0"},"_deposit":{"created_by":19,"id":"1850","owners":[19],"pid":{"revision_id":0,"type":"depid","value":"1850"},"status":"published"},"_oai":{"id":"oai:asahi-u.repo.nii.ac.jp:00001850","sets":["64:123"]},"author_link":["4108"],"item_10_creator_30":{"attribute_name":"教員氏名","attribute_type":"creator","attribute_value_mlt":[{"creatorAffiliations":[{"affiliationNameIdentifiers":[],"affiliationNames":[{"affiliationName":"朝日大学歯学部","affiliationNameLang":"ja"}]}],"creatorNames":[{"creatorName":"伊藤, 友里","creatorNameLang":"ja"},{"creatorName":"ITO, YURI","creatorNameLang":"en"}],"familyNames":[{"familyName":"伊藤","familyNameLang":"ja"},{"familyName":"ITO","familyNameLang":"en"}],"givenNames":[{"givenName":"友里","givenNameLang":"ja"},{"givenName":"YURI","givenNameLang":"en"}],"nameIdentifiers":[{"nameIdentifier":"4108","nameIdentifierScheme":"WEKO"},{"nameIdentifier":"9000240101638","nameIdentifierScheme":"CiNii ID","nameIdentifierURI":"http://ci.nii.ac.jp/nrid/9000240101638"}]}]},"item_10_date_36":{"attribute_name":"発行又は発表の年月","attribute_value_mlt":[{"subitem_date_issued_datetime":"2013-09"}]},"item_10_textarea_29":{"attribute_name":"業績分類","attribute_value_mlt":[{"subitem_textarea_value":"学術雑誌論文"}]},"item_10_textarea_31":{"attribute_name":"発行、発表雑誌等、又は発表学会等の名称","attribute_value_mlt":[{"subitem_textarea_value":"岐阜歯科学会"}]},"item_10_textarea_32":{"attribute_name":"巻","attribute_value_mlt":[{"subitem_textarea_value":"40"}]},"item_10_textarea_33":{"attribute_name":"号","attribute_value_mlt":[{"subitem_textarea_value":"2"}]},"item_10_textarea_34":{"attribute_name":"掲載ページ","attribute_value_mlt":[{"subitem_textarea_value":"119-126"}]},"item_10_textarea_35":{"attribute_name":"単著、共著の別","attribute_value_mlt":[{"subitem_textarea_value":"共著"}]},"item_10_textarea_42":{"attribute_name":"概要","attribute_value_mlt":[{"subitem_textarea_value":"　2007年からの2年間に当科でビスフォスフォネート製剤(BP製剤）投与症例での口腔外科的処置について検討した．対象は年齢， BP製剤,平均投与期間，治療内容．局所症状を考慮し抜歯時期を決め,抜歯窩の予後を比較検討した．経過良好23件，治癒遅延24件，経過不良3件であった．BP製剤休薬期間は抜歯の予後と関連がみられないが，抜歯の予後とBP製剤総投与量とは関連が示唆されたので，投与量と抜歯後の治癒不全との関連が推察された．"}]},"item_access_right":{"attribute_name":"アクセス権","attribute_value_mlt":[{"subitem_access_right":"metadata only access","subitem_access_right_uri":"http://purl.org/coar/access_right/c_14cb"}]},"item_language":{"attribute_name":"言語","attribute_value_mlt":[{"subitem_language":"jpn"}]},"item_resource_type":{"attribute_name":"資源タイプ","attribute_value_mlt":[{"resourcetype":"other","resourceuri":"http://purl.org/coar/resource_type/c_1843"}]},"item_title":"ビスフォスフォネート製剤投与患者の臨床的検討","item_titles":{"attribute_name":"タイトル","attribute_value_mlt":[{"subitem_title":"ビスフォスフォネート製剤投与患者の臨床的検討"}]},"item_type_id":"10","owner":"19","path":["123"],"pubdate":{"attribute_name":"公開日","attribute_value":"2015-02-10"},"publish_date":"2015-02-10","publish_status":"0","recid":"1850","relation_version_is_last":true,"title":["ビスフォスフォネート製剤投与患者の臨床的検討"],"weko_creator_id":"19","weko_shared_id":-1},"updated":"2024-01-15T02:04:32.892955+00:00"}